YOLFTbeta
00

Zhejiang Dayang Biotech Group Co

003017 · SHE · Basic Materials / Chemicals

21.43CNY-0.41 (-1.88%)

Price History

Full chart

Market Stats

Previous Close21.84
Open22.64
Day Range21.24 – 23.18
52-Week Range18.57 – 30.00
Volume8.45M
Market Cap2.28B
P/E (TTM)23.33
Forward P/E0.00
EPS0.97
Dividend Yield2.65%
Beta0.52
50-Day Avg22.10
200-Day Avg24.51

About

Zhe Jiang Dayang Biotech Group Co., Ltd. operates as a chemical raw material manufacturing company in China and internationally. The company offers inorganic chemicals, including potassium bicarbonate, ammonium chloride, manufactures and sales bicarbonate food and feed additives; veterinary drugs; potassium bicarbonate; and ammonium chloride. It also provides 2-chloro-6-fluorobenzoic acid, fluorobenzaldehyde, and fluorobenzyl chloride. In addition, it offers aminopropionate hydrochloride. Further, it engages in the wholesale and retail of pharmaceutical intermediates; and research and development of industrial enzyme preparations and biological feeds. The company was founded in 1976 and is based in Jiande, China.

Company Details

  • SectorBasic Materials
  • IndustryChemicals
  • CEOMs. Xujun Chen
  • Employees771
  • HeadquartersNo. 22 Chaoyang Road, Jiande, China, 311616, China
  • Websitehttps://www.dyhg.com

Leadership

  • Ms. Xujun ChenGM, Financial Director & Director · b. 1978
  • Mr. Xianyu WangExecutive Deputy GM & Vice Chairman · b. 1960
  • Mr. Weijun GuanDeputy GM & Director · b. 1964
  • Mr. Yongsheng QiuDeputy GM & Director · b. 1960
  • Mr. Guoping WangR&D Center Director & Director · b. 1974
  • Mr. Xuping XuBoard Secretary · b. 1965
  • Mr. Yuan LiChairman of the Supervisory Board & Deputy Director of Human Resources Department · b. 1986

Financials

Income Statement

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue499.72M458.57M448.10M441.23M554.72M584.16M621.75M678.34M783.21M1.06B919.45M909.96M1.05B
Growth (%)--8.24%-2.28%-1.53%+25.72%+5.31%+6.44%+9.10%+15.46%+35.10%-13.10%-1.03%+14.89%
Cost of Revenue392.36M364.72M350.16M335.92M419.76M436.38M467.55M514.11M633.26M913.61M757.87M738.72M806.05M
Gross Profit107.37M93.84M97.94M105.31M134.96M147.78M154.20M164.23M149.95M144.49M161.58M171.24M239.39M
Gross Margin21.49%20.46%21.86%23.87%24.33%25.30%24.80%24.21%19.15%13.66%17.57%18.82%22.90%
Operating Expense84.76M86.45M83.05M88.01M77.40M69.03M67.10M62.52M70.62M85.30M105.29M95.87M116.19M
Operating Income22.61M7.39M14.90M17.30M57.56M78.75M87.10M101.71M79.33M59.19M56.29M75.37M123.20M
Operating Margin4.52%1.61%3.32%3.92%10.38%13.48%14.01%14.99%10.13%5.59%6.12%8.28%11.78%
EBITDA47.08M48.77M45.75M61.71M84.47M103.93M118.71M132.60M124.54M122.87M122.47M146.38M183.69M
EBITDA Margin9.42%10.64%10.21%13.99%15.23%17.79%19.09%19.55%15.90%11.61%13.32%16.09%17.57%
Net Income26.32M28.07M23.67M28.82M50.26M70.80M79.50M91.61M70.01M80.73M50.01M63.75M99.85M
Net Income Margin5.27%6.12%5.28%6.53%9.06%12.12%12.79%13.50%8.94%7.63%5.44%7.01%9.55%
R&D14.78M18.69M-35.40M19.63M18.23M20.48M22.33M27.84M34.06M39.22M28.78M43.78M
R&D as % of Total Revenue2.96%4.08%-8.02%3.54%3.12%3.29%3.29%3.55%3.22%4.27%3.16%4.19%
Interest Expense---7.85M4.90M2.98M1.99M1.04M4.16M6.03M6.68M7.29M4.29M
Interest Expense % of Total Revenue---1.78%0.88%0.51%0.32%0.15%0.53%0.57%0.73%0.80%0.41%

Balance Sheet

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets441.35M463.30M458.88M466.72M513.08M601.61M645.60M1.23B1.37B1.51B1.55B1.65B1.82B
Total Liabilities253.93M266.43M249.12M237.37M175.37M160.99M147.51M270.67M383.64M522.92M538.47M600.40M681.72M
Total Equity176.26M194.21M200.03M229.24M337.71M440.62M498.09M958.13M990.71M985.05M1.01B1.05B1.13B
Cash55.18M67.64M29.28M36.00M41.21M30.28M53.12M69.36M131.88M131.11M382.37M353.99M441.28M
Total Debt152.00M161.08M158.10M147.00M75.00M23.00M23.00M49.87M179.74M282.14M249.50M358.06M-
Net Debt96.82M93.45M128.82M111.00M33.79M-7.28M-30.12M-19.49M47.86M151.03M-132.00M4.07M-

Cash Flow

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow91.64M57.73M48.95M84.63M48.64M38.77M113.09M112.49M-35.16M91.89M182.42M66.19M160.11M
Investing Cash Flow-43.83M-48.06M-37.66M-51.10M-18.93M-27.15M-61.68M-492.98M8.89M-109.88M145.08M-167.30M-
Financing Cash Flow-25.51M-11.22M-18.31M-19.89M-20.77M-23.48M-27.62M396.37M89.40M16.87M-75.68M66.56M-
Capital Expenditure41.09M39.04M43.57M50.95M26.73M44.05M61.84M124.82M93.43M104.65M103.63M63.45M76.38M
Free Cash Flow50.55M18.70M5.38M33.69M21.91M-5.28M51.25M-12.33M-128.59M-12.76M78.80M2.74M83.72M
Dividends Paid18.83M18.80M9.29M22.56M27.28M23.40M23.96M13.50M36.00M34.32M42.61M42.71M54.66M
FCF to OCF55.16%32.38%10.99%39.80%45.05%-13.62%45.32%-10.96%365.77%-13.89%43.19%4.15%52.29%
Dividend Paid to FCF37.25%100.58%172.71%66.98%124.50%-443.24%46.76%-109.47%-28.00%-268.87%54.07%1556.31%65.28%

Earnings

Report DateDec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023May 21, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 21, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------------
EPS Actual0.140.250.270.170.010.080.290.130.320.200.050.170.100.210.150.200.130.350.210.300.200.320.27
Surprise-----------------------
Timing-------------After-hours---After-hours-----

Key Statistics & Ratios

Market Cap2.28B
Enterprise Value2.37B
Trailing P/E23.33
Forward P/E0.00
Price / Sales2.06
Price / Book1.98
EPS0.97
Book Value11.76
Revenue (TTM)1.11B
Gross Profit (TTM)243.47M
EBITDA178.23M
Profit Margin9.67%
Operating Margin8.70%
Return on Equity9.44%
Return on Assets3.59%
Shares Outstanding100.80M
Shares Float63.44M
Beta0.52
Dividend Yield2.65%
Dividend Rate0.60
Payout Ratio77.82%

Dividends

20261×
0.30Jun 26, 2026
20252×
0.25Oct 24, 20250.25Jun 4, 2025
20241×
0.38Jul 11, 2024
20232×
0.33Nov 14, 20230.12Jun 29, 2023
20221×
0.36Jul 8, 2022
20211×
0.36Jun 18, 2021

Stock Splits

  • Jun 26, 20261.2:1
  • Nov 14, 20231.4:1